Although the percentage of TA-MSCs in high-grade gliomas is found to be inversely correlated with overall survival, the fractions of GA-MSCs in tissues from three GBs with a wild-type IDH1 mutation status were only 0.7, 3.7 and 9.3% [60]. The gene discussed is IDH1; the disease is central nervous system cancer.